Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity

Journal of Neurochemistry

Volumn 118, Issue 5, 2011, Pages 902-914

  Sun, Kai Hui ^a   Chang, Kuei Hua ^a   Clawson, Sara ^a   Ghosh, Soumitra ^a   Mirzaei, Hamid ^a   Regnier, Fred ^a   Shah, Kavita ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; cancer; Cdk5; GSTP1; neurodegeneration; oxidative stress

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLUTATHIONE TRANSFERASE P1; PROTEIN P25; PROTEIN P35; REACTIVE OXYGEN METABOLITE; TRANSACTIVATOR PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL DEATH; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; DOWN-REGULATION; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MIDDLE AGED; NEURONS; PEROXIDASE; POSTMORTEM CHANGES; PREGNANCY; RATS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 80051788999     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07343.x     Document Type: Article

References (54)

1. Adler V., Yin Z., Fuchs S. Y., et al. (1999) Regulation of JNK signaling by GSTp. EMBO J. 18, 1321-1334. (Pubitemid 29110316)
2. Amin N. D., Albers W., and, Pant H. C., (2002) Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35. J. Neurosci. Res. 67, 354-362. (Pubitemid 34137142)
3. Becker-Hapak M., McAllister S. S., and, Dowdy S. F., (2001) TAT-mediated protein transduction into mammalian cells. Methods 24, 247-256. (Pubitemid 32846431)
4. Berhane K., Widersten M., Engstrom A., Kozarich J. W., and, Mannervik B., (1994) Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl Acad. Sci. USA 91, 1480-1484. (Pubitemid 24059036)
5. Bernardini S., Bellincampi L., Ballerini S., et al. (2005) Glutathione S-transferase P1*C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. 51, 944-951. (Pubitemid 40740873)
6. Bibb J. A., (2003) Role of Cdk5 in neuronal signaling, plasticity, and drug abuse. Neurosignals 12, 191-199. (Pubitemid 37548233)
7. Braak H., and, Braak E., (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
8. Brinkkoetter P. T., Olivier P., Wu J. S., Henderson S., Krofft R. D., Pippin J. W., Hockenbery D., Roberts J. M., and, Shankland S. J., (2009) Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells. J. Clin. Invest. 119, 3089-3101.
9. Bussière T., Giannakopoulos P., Bouras C., Perl D. P., Morrison J. H., and, Hof P. R., (2003) Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. J. Comp. Neurol. 463, 281-302. (Pubitemid 36842397)
10. Chang K. H., de Pablo Y., Lee H., Lee H., Smith M., and, Shah K., (2010) Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease. J. Neurochem. 113, 1221-1229.
11. Chang K. H., Multani P. S., Sun K. H., et al. (2011) Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Mol. Biol. Cell 22, 1452-1462.
12. Cruz J. C., Tseng H. C., Goldman J. A., Shih H., and, Tsai L. H., (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483. (Pubitemid 37494698)
13. Goodyear S., and, Sharma M. C., (2007) Roscovitine regulated invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Exp. Mol. Pathol. 82, 25-32. (Pubitemid 46038272)
14. Griffin S. V., Hiromura K., Pippin J., Petermann A. T., Blonski M. J., Krofft R., Takahashi S., Kulkarni A. B., and, Shankland S. J., (2004) Cyclin-dependent kinase 5 is a regulator of podocyte differentiation, proliferation, and morphology. Am. J. Pathol. 165, 1175-1185. (Pubitemid 39297724)
15. Grynspan F., Griffin W. R., Cataldo A., Katayama S., and, Nixon R. A., (1997) Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763, 145-158. (Pubitemid 27364434)
16. Hayes J. D., Flanagan J. U., and, Jowsey I. R., (2005) Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51-88. (Pubitemid 40261798)
17. Hisanaga S., and, Endo R., (2010) Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. J. Neurochem. 115, 1309-1321.
18. Kino T., Jaffe H., Amin N. D., Chakrabarti M., Zheng Y. L., Chrousos G. P., and, Pant H. C., (2010) Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor. Mol. Endocrinol. 24, 941-952.
19. Lee K. Y., Clark A. W., Rosales J. L., Chapman K., Fung T., and, Johnston R. N., (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci. Res. 34, 21-29. (Pubitemid 29245996)
20. Lee M. S., Kwon Y. T., Li M., Peng J., Friedlander R. M., and, Tsai L. H., (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364. (Pubitemid 30337070)
21. Lin X., and, Nelson W. G., (2003) Methyl-CpG-binding domain protein-2 mediate transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Cancer Res. 63, 498-504. (Pubitemid 36152513)
22. Lin H., Chen M. C., Chiu C. Y., Song Y. M., and, Lin S. Y., (2007) Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. J. Biol. Chem. 282, 776-784.
23. Lovell M. A., Xie C., and, Markesbery W. R., (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566. (Pubitemid 28565232)
24. Liu J. L., Wang X. Y., Huang B.X., Zhu F., Zang R.G., and, Wu G., (2010) Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis. Med. Oncol. Published Online doi:.
25. Lowman X. H., McDonnell M. A., Kosloske A., Odumade O. A., Jenness C., Karim C. B., Jemmerson R., and, Kelekar A., (2010) The proapoptotic function of Noxa in human leukemia cells is regulated by the kinase Cdk5 and by glucose. Mol. Cell 40, 823-833.
26. Maestre C., Delgado-Esteban M., Gomez-Sanchez J. C., Bolanos J. P., and, Almeida A., (2008) Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J. 27, 2736-2745.
27. Moffat J., Grueneberg D. A., Yang X., et al. (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283-1298.
28. Ohshima T., Ward J. M., Huh C. G., Longenecker G., Veeranna Pant H. C., Brady R. O., Martin L. J., and, Kulkarni A. B., (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11173-11178. (Pubitemid 26333137)
29. Pareek T. K., Lam E., Zheng X., Askew D., Kulkarni A. B., Chance M. R., Huang A. Y., Cooke K. R., and, Letterio J. J., (2010) Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 207, 2507-2519.
30. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and, Tsai L. H., (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622. (Pubitemid 129516324)
31. Petersen R. B., Nunomura A., Lee H. G., Casadesus G., Perry G., Smith M. A., and, Zhu X., (2007) Signal transduction cascades associated with oxidative stress in Alzheimer's disease. J. Alzheimers Dis. 11, 143-152. (Pubitemid 47010981)
32. Pinhel M. A., Nakazone M. A., Cação J. C., Piteri R. C., Dantas R. T., Godoy M. F., Godoy M. R., Tognola W. A., Conforti-Froes N. D., and, Souza D., (2008) Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. Lab. Med. 46, 439-445. (Pubitemid 351820359)
33. Ralat L. A., Manevich Y., Fisher A. B., and, Colman R. F., (2006) Direct evidence for the formation of a complex between 1-cysteine peroxiredoxin and glutathione S-transferase pi with activity changes in both enzymes. Biochemistry 45, 360-372. (Pubitemid 43100403)
34. Rosales J. L., and, Lee K. Y., (2006) Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 28, 1023-1034. (Pubitemid 44570451)
35. Sahlgren C. M., Mikhailov A., Vaittinen S., Pallari H. M., Kalimo H., Pant H. C., and, Eriksson J. E., (2003) Cdk5 regulates the organization of Nestin and its association with p35. Mol. Cell. Biol. 23, 5090-5106. (Pubitemid 36793352)
36. Saito T., Konno T., Hosokawa T., Asada A., Ishiguro K., and, Hisanaga S. I., (2007) p25/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons. J. Neurochem. 102, 133-140. (Pubitemid 46906270)
37. Shea T. B., Zheng Y. L., Ortiz D., and, Pant H. C., (2004) Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress. J. Neurosci. Res. 76, 795-800. (Pubitemid 38720686)
38. Shi M., Bradner J., Bammler T. K., Eaton D. L., Zhang J. P., Ye Z. C., Wilson A. M., Montine T. J., Pan C., and, Zhang J., (2009) Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am. J. Pathol. 175, 54-65.
39. Strange R. C., Spiteri M. A., Ramachandran S., and, Fryer A. A., (2001) Glutathione-S-transferase family of enzymes. Mutat. Res. 482, 21-26. (Pubitemid 32787078)
40. Strock C. J., Park J. I., Nakakura E. K., Bova G. S., Isaacs J. T., Ball D. W., and, Nelkin B. D., (2006) Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells. Cancer Res. 66, 7509-7515. (Pubitemid 44289205)
41. Sun K. H., de Pablo Y., Vincent F., Johnson E. O., Chavers A. K., and, Shah K., (2008a) Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol. Biol. Cell 19, 3052-3069.
42. Sun K. H., de Pablo Y., Vincent F., and, Shah K., (2008b) Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J. Neurochem. 107, 265-278.
43. 2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease. Mol. Biol. Cell 20, 4611-4619.
44. Tandon A., Yu H., Wang L., et al. (2003) Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. J. Neurochem. 86, 572-581. (Pubitemid 36897438)
45. Tang X., Wang X., Gong X., Tong M., Park D., Xia Z., and, Mao Z., (2005) Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 25, 4823-4834. (Pubitemid 40664130)
46. Taniguchi S., Fujita Y., Hayashi S., Katita A., Takahashi H., Murayana S., Saido T. C., Hisanaga S., Iwatsubo T., and, Hasegawa M., (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett. 489, 46-50. (Pubitemid 32176003)
47. Tian B., Yang Q., and, Mao Z., (2009) Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Nat. Cell Biol. 11, 211-218.
48. Tseng H. C., Zhou Y., Shen Y., and, Tsai L. H., (2002) A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett. 523, 58-62. (Pubitemid 34786058)
49. Wei F. Y., Nagashima K., Ohshima T., et al. (2005) Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat. Med. 11, 1104-1108. (Pubitemid 41486833)
50. Wen Y., Yu W. H., Maloney B., et al. (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57, 680-690. (Pubitemid 351335351)
51. Wu Y., Xue B., Luo L., Shen J., Zhang S., Jiang Y., and, Yin Z., (2006) Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25, 5787-5800. (Pubitemid 44435255)
52. Yang F., Liu Y., Bixby S. D., Friedman J. D., and, Shokat K. M., (1999) Highly efficient green fluorescent protein-based kinase substrates. Anal. Biochem. 266, 167-173. (Pubitemid 29047477)
53. Yoo B. C., and, Lubec G., (2001) p25 protein in neurodegeneration. Nature 411, 763-764; discussion 764-765.
54. Zheng Y. L., Li B. S., Rudrabhatla P., et al. (2010) Phosphorylation of p27Kip1 at Thr187 by cyclin-dependent kinase 5 modulates neural stem cell differentiation. Mol. Biol. Cell 21, 3601-3614.